Steffen LE, et al. - In this study, predictors of BRCA1/2 testing were assessed among breast and ovarian cancer survivors who received genetic counseling as part of a randomized trial and moderators of counseling mode on testing uptake were determined. Researchers recognized cost concerns as a strong determinant of testing. Pre-counseling distress and risk perceptions seemed to influence the differences in testing uptake by counseling mode. In population-based samples of at risk cancer survivors, cost concerns could contribute to low testing. They recommended considering pre-counseling psychosocial characteristics when offering in-person vs. telephone counseling.